S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S- (dimethylarsino) glutathione as treatments for cancer

Mérida Sotelo Lerma (Inventor), R. A. Zingaro (Inventor)

Research output: Patent

Abstract

Arsenic trioxide, an inorganic compound, is commercially available anti-cancer agent but it carries significant toxicity. Organic arsenicals, on the other hand, are much less toxic, to the extent that the methylation of inorganic arsenic in vivo into organic arsenicals has been considered a detoxification reaction. New organic arsenic derivatives have been synthesized, including S-dimethylarsino-glutathione, S-dimethylarsino-thiosuccinic acid and S-dimethylarsino-thiobenzoic acid, and established its potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia. Results form a basis for the development of S-dimethylarsino-glutathione, S-dimethylarsino-thiosuccinic acid, S-dimethylarsino-thiobenzoic acid, and other organic arsenicals as an anti-cancer therapy, combining high efficacy with very low, if any, toxicity.
Original languageEnglish
Patent number07619000
IPCUS,20060189687
Priority date24/08/06
Filing date17/11/09
StatePublished - 17 Nov 2009

Cite this